Berkshire Hathaway Inc.
Berkshire Hathaway Inc. (BRK-B) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Berkshire Hathaway Inc. (BRK-B), featuring income statements, balance sheets, and cash flow data.
Berkshire Hathaway Inc. (BRK-B) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Berkshire Hathaway Inc. BRK-B financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $89.72B | $94.92B | $93.00B | $93.65B |
| Cost of Revenue | $15.71B | $14.50B | $16.09B | $15.06B |
| Gross Profit | $67.58B | $86.97B | $97.42B | $102.45B |
| Gross Profit Ratio | $0.75 | $0.92 | $1.05 | $1.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.57B | $10.21B | $9.10B | $6.93B |
| Operating Expenses | $62.43B | $62.94B | $64.91B | $64.31B |
| Total Costs & Expenses | $83.45B | $70.33B | $59.49B | $79.37B |
| Interest Income | $5.63B | $6.38B | $5.90B | $5.25B |
| Interest Expense | $1.26B | $1.44B | $1.21B | $1.23B |
| Depreciation & Amortization | $3.27B | $3.28B | $3.21B | $3.20B |
| EBITDA | $9.67B | $28.75B | $36.93B | $42.56B |
| EBITDA Ratio | $0.11 | $0.30 | $0.40 | $0.45 |
| Operating Income | $6.41B | $25.46B | $33.72B | $37.88B |
| Operating Income Ratio | $0.07 | $0.27 | $0.36 | $0.40 |
| Other Income/Expenses (Net) | -$1.26B | $2.31B | $19.52B | $252.00M |
| Income Before Tax | $5.15B | $24.02B | $32.51B | $38.14B |
| Income Before Tax Ratio | $0.06 | $0.25 | $0.35 | $0.41 |
| Income Tax Expense | $476.00M | $4.27B | $6.03B | $7.64B |
| Net Income | $4.60B | $19.69B | $26.25B | $30.35B |
| Net Income Ratio | $0.05 | $0.21 | $0.28 | $0.32 |
| EPS | $2.13 | $9.13 | $12.18 | $14.08 |
| Diluted EPS | $2.13 | $9.13 | $12.18 | $14.08 |
| Weighted Avg Shares Outstanding | $2.16B | $2.16B | $2.16B | $2.16B |
| Weighted Avg Shares Outstanding (Diluted) | $2.16B | $2.16B | $2.16B | $2.16B |
Financial performance has remained strong, with revenue growing from $93.65B in Q2 2024 to $89.72B in Q1 2025. Gross profit continued to perform well, with margins at 75% in the latest quarter. Operating income reached $6.41B in Q1 2025, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $9.67B. Net income dropped to $4.60B, keeping EPS at $2.13. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan